
Singapore · Biotechnology
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Public · NASDAQ:ASLNFor profit
Set against 55 Biotechnology companies in Singapore. The ring marks the typical peer.
Across all 5.9M companies: larger than 33% of those with a size listed; older than 5% of those with a founding year; website ranked #1,588,125 in the world, about 15k visits a month.
BiotechnologyHealth CareMedicalOncologyPharmaceutical
What the source datasets report. We have not watched these rounds ourselves.
$186M
raised in total, currency not stated across 10 rounds
Last raised Mar 2024, 2 years ago
Who started it and how it trades.
Everything the source datasets list about ASLAN Pharmaceuticals, field by field. Contact details are held but never shown.
The company7 fields
Where3 fields
Size and reach3 fields
Funding, as listed8 fields
About this record2 fields
Growth, as the source summarises it
ASLAN Pharmaceuticals faced delisting from Nasdaq.
55 Biotechnology companies in Singapore, filtered by size, age and reach, ready to export with emails on Pro.